news
BioNTech launches MammaTyper breast cancer diagnostic test in Europe
11 June 2015 | By Victoria White
BioNTech has launched MammaTyper, a molecular diagnostic test for breast cancer, for universal use in pathology laboratories in Europe...
List view / Grid view
Biomarkers
Biomarkers are a naturally occurring molecule, gene, or characteristic by which a particular disease can be identified.
news
Analysis of human aqueous humour reveals 386 new proteins as biomarker candidates
1 June 2015 | By Victoria White
Researchers analysing human aqueous humour samples have identified 763 proteins – including 386 proteins detected for the first time...
news
The Michael J. Fox Foundation and Prothena partner to accelerate discovery of novel biomarkers for Parkinson’s disease
5 May 2015 | By Victoria White
MJFF and Prothena have teamed up to accelerate the discovery of novel biomarkers and development of assays to measure Parkinson's disease progression...
news
International consortium CANCER-ID to develop novel biomarker technologies in cancer
23 April 2015 | By Victoria White
Bayer and UKE are the main coordinators of a new international consortium, CANCER-ID, to develop novel blood-based biomarker technologies in cancer...
news
Detecting prostate tumour cells in blood can give an early warning of treatment failure
23 March 2015 | By Victoria White
A blood test that measures the number of prostate tumour cells shed into the bloodstream can act as an early warning sign that treatment is not working...
news
Launch of the anti-cancer agent / BRAF inhibitor “Zelboraf”
26 February 2015 | By Roche
Contribution to the treatment of melanoma by personalized healthcare...
news
Oncologic imaging innovation is enabling earlier detection of cancers
4 February 2015 | By Frost & Sullivan
Ongoing research aims to develop oncologic imaging technologies that diagnose cancer at the cellular level before the disease manifests, finds Frost & Sullivan...
news
BerGenBio receives orphan-drug designation from FDA for BGB324 in the treatment of acute myeloid leukaemia
19 November 2014 | By BerGenBio
BerGenBio AS, an oncology biopharmaceutical company, announces that the US Food and Drug Administration (FDA) has granted orphan-drug designation for BGB324 for treatment of acute myeloid leukaemia (AML)...
news
Probiodrug sponsors 5th Biannual NUBIN Symposium on Biomarkers in Neurodegenerative Diseases
29 October 2014 | By Probiodrug AG
Probiodrug AG, a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease, has announced it is the Silver sponsor of the 5th Biannual NUBIN Symposium on Biomarkers in Neurodegenerative Disease taking place on October 29th and 30th in Amsterdam.
article
Synthetic macrocyclic receptors as tools in drug delivery and drug discovery
Macrocyclic compounds (see Figure 1) have fascinated medicinal chemists for generations. The first ones which have been characterised are the naturally occurring cyclodextrins (CDs), cyclic oligomers of glucose, which can be obtained by bacterial synthesis from starch. Calixarenes (CXs) were among the first man-made macrocycles, followed by crown ethers (Pedersen,…
news
Event preview: Drug Discovery Week Europe
3 October 2014 | By GTCbio
From 7-10 October 2014, GTCbio will proudly present its Drug Discovery Week Europe event in the beautiful city of Dublin, Ireland...
news
Tumour profiling with Caris Molecular Intelligence offers hope for patients with rare cancers by identifying new personalised treatment options
29 September 2014 | By Caris Life Sciences
Caris Life Sciences announced important new data presented at the European Society for Medical Oncology Annual Conference, highlighting how tumour profiling with Caris Molecular Intelligence can help transform cancer care...
news
AstraZeneca advances tralokinumab to Phase III in severe asthma
14 August 2014 | By AstraZeneca
AstraZeneca announced the start of the Phase III programme for tralokinumab, a potential treatment for patients with severe, inadequately controlled asthma, developed by MedImmune, the company’s global biologics research and development arm...
news
Fraunhofer IME integrates European ScreeningPort to enhance its expertise and capabilities in drug discovery
9 July 2014 | By Fraunhofer IME
The operative business of European ScreeningPort GmbH has been integrated into the Fraunhofer Institute for Molecular Biology and Applied Ecology IME located in Aachen...
news
DaVita Labs and Myriad RBM announce biomarker research collaboration
7 July 2014 | By Myriad RBM
Collaboration will focus on development of novel diagnostic tests for dialysis patients...
